The 2016 surviving sepsis guideline suggested the use of albumin for patients with sepsis and septic shock when patients require substantial amounts of crystalloids (weak recommendation, low quality of evidence)7, but there is a lack of evidence for septic shock patients with AKI. This evidence concerns the gene ALB and acute kidney injury.